How is the Lipella Pharmaceuticals Inc today?

The Lipella Pharmaceuticals Inc today is trading in the down by -0.34% at 2.93.

What is Lipella Pharmaceuticals Inc Annual Revenue?

Lipella Pharmaceuticals Inc Annual Revenue rose 19.29%, in the last year to $0.54 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Lipella Pharmaceuticals Inc Annual Net Profit?

Lipella Pharmaceuticals Inc Annual Net Profit fell 8.6% in the last year to $5.02 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Lipella Pharmaceuticals Inc Price to Earning Ratio?

Lipella Pharmaceuticals Inc Price to Earning Ratio is -2.55, which is negative.

What is Lipella Pharmaceuticals Inc Stock Price?

Lipella Pharmaceuticals Inc Stock Price fell 43% and underperformed its sector by 69.54% in the past year.

What is Lipella Pharmaceuticals Inc Quarterly Net profit?

Lipella Pharmaceuticals Inc Quarterly Net profit fell 9.62% YoY to $1.31 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Lipella Pharmaceuticals Inc Debt to Equity Ratio?

Lipella Pharmaceuticals Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Lipella Pharmaceuticals Inc Return on Equity(ROE)?

Lipella Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -198.12%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Lipella Pharmaceuticals Inc Mutual Fund Holding?

Lipella Pharmaceuticals Inc Mutual Fund Holding decreased by 0.16% in the last quarter to 1.05.

What is Lipella Pharmaceuticals Inc Institutional Holding?

Lipella Pharmaceuticals Inc Institutional Holding decreased by 0.5% in the last quarter to 0.74.

Lipella Pharmaceuticals Inc XNAS: LIPO

Lipella Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Lipella Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Lipella Pharmaceuticals Inc
Rating: 1.44675
Author: Trendlyne DVM scores

about

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's...

2.93 -0.01 (-0.34%)

75.58% Fall from 52W High

16,325 XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

7.5 / 100

Technically Neutral

50.4 / 100

10

1Yr Price target upside is 241%

1 analysts

Lipella Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lipella Pharmaceuticals Inc FAQ

How is Lipella Pharmaceuticals Inc today?

Lipella Pharmaceuticals Inc today is trading in the red, and is down by -0.34% at 2.93.

How has Lipella Pharmaceuticals Inc performed historically?

Lipella Pharmaceuticals Inc is currently trading down -0.34% on an intraday basis. In the past week the stock rose 1.03%. stock has been down 0.00% in the past quarter and fell -43.00% in the past year. You can view this in the overview section.